It is known that the salary cap (currently estimated at $88 million) is going to rise significantly in the coming years.

Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

The snacking giant secured licensing deals in the frozen aisle for two staple brands, and Graeter’s Ice Cream partnered with ...

In a report released today, Bill Kirk from Roth MKM maintained a Buy rating on High Tide (HITI – Research Report), with a price target of ...

Molson Coors has acquired an 8.5% stake in British drinks company Fever Tree in a £71m deal that enables the mixer brand to ...

Procurement software demand is driven by digital transformation, AI, and sustainability, with key players like SAP Ariba and ...

Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long ...

Innovate UK temporarily halts its £25m Smart Grants scheme for SMEs as oversubscription, low success rates, and a new focus ...

The FTSE 100 index has started the year well as it surged to a record high. It moved to a high of £8,645, up by over 75% from ...

Barclays analyst Lauren Lieberman maintained a Sell rating on Church & Dwight (CHD – Research Report) today and set a price target of ...